Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) was the target of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 12,620,000 shares, a drop of 11.0% from the May 15th total of 14,180,000 shares. Based on an average daily volume of 1,660,000 shares, the […]
HC Wainwright reiterated their buy rating on shares of Atara Biotherapeutics (NASDAQ:ATRA – Get Rating) in a report published on Wednesday morning, The Fly reports. HC Wainwright currently has a $28.00 price target on the biotechnology company’s stock, up from their prior price target of $27.00. HC Wainwright also issued estimates for Atara Biotherapeutics’ Q2 […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 12,620,000 shares, a decrease of 11.0% from the May 15th total of 14,180,000 shares. Based on an average daily volume of 1,660,000 shares, the days-to-cover ratio is […]
Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 12,620,000 shares, a decrease of 11.0% from the May 15th total of 14,180,000 shares. Based on an average daily volume of 1,660,000 shares, the days-to-cover ratio is […]
Josh Arnold Investment Consultant LLC raised its position in Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Rating) by 73.3% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 52,000 shares of the biotechnology company’s stock after acquiring an additional 22,000 shares during the period. Atara Biotherapeutics makes up about […]